Minerva Neurosciences (NERV) Assets (2013 - 2026)
Minerva Neurosciences (NERV) reported Assets of $95.09 million for Q2 2026, up 212.6% from $30.42 million a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Minerva Neurosciences posted Assets of $97.97 million, up 163.8% from FY2024.
- Assets has a five-year compound annual growth rate of 11.2% (FY2020 to FY2025).
- By year, Assets came in at $37.14 million in FY2024 (-34.7%), $56.9 million in FY2023 (+3.3%), $55.09 million in FY2022 (-28.6%) and $77.12 million in FY2021 (+33.8%).
- Five-year quarterly Assets spans a low of $28.09 million in Q3 2025 and a high of $97.97 million in Q4 2025.
- Year over year, Assets has now increased in each of the last three quarters, with growth averaging 49.0% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2026 (growth of 212.6%); the low point was Q3 2022 (a decline of 38.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $94.03 million (Q1 2026), $97.97 million (Q4 2025) and $28.09 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Minerva Neurosciences | 117.90 Mn | -130.03 Mn | - | 95.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.09 Mn |
| Mar 31, 2026 | 94.03 Mn |
| Dec 31, 2025 | 97.97 Mn |
| Sep 30, 2025 | 28.09 Mn |
| Jun 30, 2025 | 30.42 Mn |
| Mar 31, 2025 | 32.80 Mn |
| Dec 31, 2024 | 37.14 Mn |
| Sep 30, 2024 | 42.81 Mn |
| Jun 30, 2024 | 46.29 Mn |
| Mar 31, 2024 | 50.51 Mn |
| Dec 31, 2023 | 56.90 Mn |
| Sep 30, 2023 | 63.13 Mn |
| Jun 30, 2023 | 67.14 Mn |
| Mar 31, 2023 | 51.59 Mn |
| Dec 31, 2022 | 55.09 Mn |
| Sep 30, 2022 | 59.76 Mn |
| Jun 30, 2022 | 64.96 Mn |
| Mar 31, 2022 | 70.62 Mn |
| Dec 31, 2021 | 77.12 Mn |
| Sep 30, 2021 | 97.56 Mn |
API Access
Minerva Neurosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();